A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLAGUNJU, Abolaji Samson et al. Memory T cells, recombinant Listeria monocytogenes, and cancer vaccines. Frontiers in Bioscience, v. 30, 2025Tradução . . Disponível em: https://doi.org/10.31083/FBL36329. Acesso em: 27 nov. 2025.
APA
Olagunju, A. S., Loza, M. L., Rocha, M. C., & Amarante-Mendes, J. G. P. (2025). Memory T cells, recombinant Listeria monocytogenes, and cancer vaccines. Frontiers in Bioscience, 30. doi:10.31083/FBL36329
NLM
Olagunju AS, Loza ML, Rocha MC, Amarante-Mendes JGP. Memory T cells, recombinant Listeria monocytogenes, and cancer vaccines [Internet]. Frontiers in Bioscience. 2025 ; 30[citado 2025 nov. 27 ] Available from: https://doi.org/10.31083/FBL36329
Vancouver
Olagunju AS, Loza ML, Rocha MC, Amarante-Mendes JGP. Memory T cells, recombinant Listeria monocytogenes, and cancer vaccines [Internet]. Frontiers in Bioscience. 2025 ; 30[citado 2025 nov. 27 ] Available from: https://doi.org/10.31083/FBL36329
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MINUZZI, Luciele Guerra et al. Natural killer cells from endurance-trained older adults show improved functional and metabolic responses to adrenergic blockade and mTOR inhibition. Scientific Reports, v. 15, p. 14 , 2025Tradução . . Disponível em: https://doi.org/10.1038/s41598-025-06057-y. Acesso em: 27 nov. 2025.
APA
Minuzzi, L. G., Batatinha, H. A. P., Weyh, C., Lakshmi, V. S. B., Fiuza-Luces, C., Gálvez, B. G., et al. (2025). Natural killer cells from endurance-trained older adults show improved functional and metabolic responses to adrenergic blockade and mTOR inhibition. Scientific Reports, 15, 14 . doi:10.1038/s41598-025-06057-y
NLM
Minuzzi LG, Batatinha HAP, Weyh C, Lakshmi VSB, Fiuza-Luces C, Gálvez BG, Lucia A, Teixeira AM, Sommer N, Rosa Neto JC, Lira FS, Krüger K. Natural killer cells from endurance-trained older adults show improved functional and metabolic responses to adrenergic blockade and mTOR inhibition [Internet]. Scientific Reports. 2025 ; 15 14 .[citado 2025 nov. 27 ] Available from: https://doi.org/10.1038/s41598-025-06057-y
Vancouver
Minuzzi LG, Batatinha HAP, Weyh C, Lakshmi VSB, Fiuza-Luces C, Gálvez BG, Lucia A, Teixeira AM, Sommer N, Rosa Neto JC, Lira FS, Krüger K. Natural killer cells from endurance-trained older adults show improved functional and metabolic responses to adrenergic blockade and mTOR inhibition [Internet]. Scientific Reports. 2025 ; 15 14 .[citado 2025 nov. 27 ] Available from: https://doi.org/10.1038/s41598-025-06057-y
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARROS, Rafael dos Santos et al. Effects of low-dose rapamycin on lymphoid organs of mice prone and resistant to accelerated senescence. Frontiers in Immunology, v. 15, p. 14 , 2024Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2024.1310505. Acesso em: 27 nov. 2025.
APA
Barros, R. dos S., Queiroz, L. A. D. de, Pantoja, K. da C., Bustia, S. X., Sousa, E. S. A. de, Assis, J. B. de, et al. (2024). Effects of low-dose rapamycin on lymphoid organs of mice prone and resistant to accelerated senescence. Frontiers in Immunology, 15, 14 . doi:10.3389/fimmu.2024.1310505
NLM
Barros R dos S, Queiroz LAD de, Pantoja K da C, Bustia SX, Sousa ESA de, Assis JB de, Rodrigues SF de P, Akamine EH, Nunes A de S, Martins J de O. Effects of low-dose rapamycin on lymphoid organs of mice prone and resistant to accelerated senescence [Internet]. Frontiers in Immunology. 2024 ; 15 14 .[citado 2025 nov. 27 ] Available from: https://doi.org/10.3389/fimmu.2024.1310505
Vancouver
Barros R dos S, Queiroz LAD de, Pantoja K da C, Bustia SX, Sousa ESA de, Assis JB de, Rodrigues SF de P, Akamine EH, Nunes A de S, Martins J de O. Effects of low-dose rapamycin on lymphoid organs of mice prone and resistant to accelerated senescence [Internet]. Frontiers in Immunology. 2024 ; 15 14 .[citado 2025 nov. 27 ] Available from: https://doi.org/10.3389/fimmu.2024.1310505
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
IGNACIO, Aline et al. Lack of mTORC2 signaling in CD11c+ myeloid cells inhibits their migration and ameliorates experimental colitis. Journal of Leukocyte Biology, v. 116, n. 4, p. 779-792, 2024Tradução . . Disponível em: https://doi.org/10.1093/jleuko/qiae084. Acesso em: 27 nov. 2025.
APA
Ignacio, A., Cipelli, M., Takiishi, T., Aguiar, C. F., Terra, F. F., Ghirotto, B., et al. (2024). Lack of mTORC2 signaling in CD11c+ myeloid cells inhibits their migration and ameliorates experimental colitis. Journal of Leukocyte Biology, 116( 4), 779-792. doi:10.1093/jleuko/qiae084
NLM
Ignacio A, Cipelli M, Takiishi T, Aguiar CF, Terra FF, Ghirotto B, Silva EM da, Castoldi A, Magalhães YT, Antonio T, Padovani BN, Hiyane MI, Andrade-Oliveira V, Forti FL, Camara NOS. Lack of mTORC2 signaling in CD11c+ myeloid cells inhibits their migration and ameliorates experimental colitis [Internet]. Journal of Leukocyte Biology. 2024 ; 116( 4): 779-792.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1093/jleuko/qiae084
Vancouver
Ignacio A, Cipelli M, Takiishi T, Aguiar CF, Terra FF, Ghirotto B, Silva EM da, Castoldi A, Magalhães YT, Antonio T, Padovani BN, Hiyane MI, Andrade-Oliveira V, Forti FL, Camara NOS. Lack of mTORC2 signaling in CD11c+ myeloid cells inhibits their migration and ameliorates experimental colitis [Internet]. Journal of Leukocyte Biology. 2024 ; 116( 4): 779-792.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1093/jleuko/qiae084
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORIM, Patricia Aparecida et al. Effect of rapamycin on MOG-Reactive immune cells and lipopolysaccharide-activated microglia: an in vitro approach for screening new therapies for multiple sclerosis. Journal of Interferon & Cytokine Research, v. 42, n. 4, p. 1-8, 2022Tradução . . Disponível em: https://doi.org/10.1089/jir.2021.0206. Acesso em: 27 nov. 2025.
APA
Borim, P. A., Mimura, L. A. N., Pezavento, S. F. G. Z., Polonio, C. M., Peron, J. P. S., Sartori, A., & Silva, T. F. de C. F. (2022). Effect of rapamycin on MOG-Reactive immune cells and lipopolysaccharide-activated microglia: an in vitro approach for screening new therapies for multiple sclerosis. Journal of Interferon & Cytokine Research, 42( 4), 1-8. doi:10.1089/jir.2021.0206
NLM
Borim PA, Mimura LAN, Pezavento SFGZ, Polonio CM, Peron JPS, Sartori A, Silva TF de CF. Effect of rapamycin on MOG-Reactive immune cells and lipopolysaccharide-activated microglia: an in vitro approach for screening new therapies for multiple sclerosis [Internet]. Journal of Interferon & Cytokine Research. 2022 ; 42( 4): 1-8.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1089/jir.2021.0206
Vancouver
Borim PA, Mimura LAN, Pezavento SFGZ, Polonio CM, Peron JPS, Sartori A, Silva TF de CF. Effect of rapamycin on MOG-Reactive immune cells and lipopolysaccharide-activated microglia: an in vitro approach for screening new therapies for multiple sclerosis [Internet]. Journal of Interferon & Cytokine Research. 2022 ; 42( 4): 1-8.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1089/jir.2021.0206
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TEJADA, Nathália Franchon Marques et al. AIM2 as a putative target in acute kidney graft rejection. Frontiers in Immunology, v. 13, p. 1-15, 2022Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2022.839359. Acesso em: 27 nov. 2025.
APA
Tejada, N. F. M., Lopes, J. V. Z., Gonçalves, L. E. D., Conceição, I. M. C. A. da, Franco, G. R., Nunes, B. G., & Câmara, N. O. S. (2022). AIM2 as a putative target in acute kidney graft rejection. Frontiers in Immunology, 13, 1-15. doi:10.3389/fimmu.2022.839359
NLM
Tejada NFM, Lopes JVZ, Gonçalves LED, Conceição IMCA da, Franco GR, Nunes BG, Câmara NOS. AIM2 as a putative target in acute kidney graft rejection [Internet]. Frontiers in Immunology. 2022 ; 13 1-15.[citado 2025 nov. 27 ] Available from: https://doi.org/10.3389/fimmu.2022.839359
Vancouver
Tejada NFM, Lopes JVZ, Gonçalves LED, Conceição IMCA da, Franco GR, Nunes BG, Câmara NOS. AIM2 as a putative target in acute kidney graft rejection [Internet]. Frontiers in Immunology. 2022 ; 13 1-15.[citado 2025 nov. 27 ] Available from: https://doi.org/10.3389/fimmu.2022.839359
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PAGNI, Roberta Liberato et al. Interleukin-6 and indoleamine-2,3-dioxygenase as potential adjuvant targets for Papillomavirus-related tumors immunotherapy. Frontiers in Immunology, v. 13, p. 1-15, 2022Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2022.1005937. Acesso em: 27 nov. 2025.
APA
Pagni, R. L., Souza, P. da C., Pegoraro, R., Ribeiro, B. F. M. M. P., Silva, J. R. da, Aps, L. R. de M. M., et al. (2022). Interleukin-6 and indoleamine-2,3-dioxygenase as potential adjuvant targets for Papillomavirus-related tumors immunotherapy. Frontiers in Immunology, 13, 1-15. doi:10.3389/fimmu.2022.1005937
NLM
Pagni RL, Souza P da C, Pegoraro R, Ribeiro BFMMP, Silva JR da, Aps LR de MM, Silva M de O, Rodrigues KB, Sales NS, Ferreira LC de S, Moreno ACR. Interleukin-6 and indoleamine-2,3-dioxygenase as potential adjuvant targets for Papillomavirus-related tumors immunotherapy [Internet]. Frontiers in Immunology. 2022 ; 13 1-15.[citado 2025 nov. 27 ] Available from: https://doi.org/10.3389/fimmu.2022.1005937
Vancouver
Pagni RL, Souza P da C, Pegoraro R, Ribeiro BFMMP, Silva JR da, Aps LR de MM, Silva M de O, Rodrigues KB, Sales NS, Ferreira LC de S, Moreno ACR. Interleukin-6 and indoleamine-2,3-dioxygenase as potential adjuvant targets for Papillomavirus-related tumors immunotherapy [Internet]. Frontiers in Immunology. 2022 ; 13 1-15.[citado 2025 nov. 27 ] Available from: https://doi.org/10.3389/fimmu.2022.1005937
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NORONHA, Nádia de Cássia. Efeitos do pré-condicionamento com hipóxia e/ou interleucina-17 em células estromais mesenquimais de cordão umbilical cultivadas em biorreator de tanque agitado. 2021. Tese (Doutorado) – Universidade de São Paulo, Ribeirão Preto, 2021. Disponível em: https://www.teses.usp.br/teses/disponiveis/60/60140/tde-24032022-155059/. Acesso em: 27 nov. 2025.
APA
Noronha, N. de C. (2021). Efeitos do pré-condicionamento com hipóxia e/ou interleucina-17 em células estromais mesenquimais de cordão umbilical cultivadas em biorreator de tanque agitado (Tese (Doutorado). Universidade de São Paulo, Ribeirão Preto. Recuperado de https://www.teses.usp.br/teses/disponiveis/60/60140/tde-24032022-155059/
NLM
Noronha N de C. Efeitos do pré-condicionamento com hipóxia e/ou interleucina-17 em células estromais mesenquimais de cordão umbilical cultivadas em biorreator de tanque agitado [Internet]. 2021 ;[citado 2025 nov. 27 ] Available from: https://www.teses.usp.br/teses/disponiveis/60/60140/tde-24032022-155059/
Vancouver
Noronha N de C. Efeitos do pré-condicionamento com hipóxia e/ou interleucina-17 em células estromais mesenquimais de cordão umbilical cultivadas em biorreator de tanque agitado [Internet]. 2021 ;[citado 2025 nov. 27 ] Available from: https://www.teses.usp.br/teses/disponiveis/60/60140/tde-24032022-155059/
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTRO, Érique de et al. Adipocyte-specific mTORC2 deficiency impairs BAT and iWAT thermogenic capacity without affecting glucose uptake and energy expenditure in coldacclimated mice. AJP: Endocrinology and Metabolism, v. 321, p. E592–E605, 2021Tradução . . Disponível em: https://doi.org/10.1152/ajpendo.00587.2020. Acesso em: 27 nov. 2025.
APA
Castro, É. de, Vieira, T. dos S., Oliveira, T. E., Silva, M. O., Andrade, M. L., Tomazelli, C. A., et al. (2021). Adipocyte-specific mTORC2 deficiency impairs BAT and iWAT thermogenic capacity without affecting glucose uptake and energy expenditure in coldacclimated mice. AJP: Endocrinology and Metabolism, 321, E592–E605. doi:10.1152/ajpendo.00587.2020
NLM
Castro É de, Vieira T dos S, Oliveira TE, Silva MO, Andrade ML, Tomazelli CA, Peixoto AS, Sobrinho CR, Moreno MF, Gilio GR, Moreira RJ, Guimarães RC, Perandini LAB, Chimin P, Reckziegel P, Moretti EH, Steiner AA, Laplante M, Festuccia WTL. Adipocyte-specific mTORC2 deficiency impairs BAT and iWAT thermogenic capacity without affecting glucose uptake and energy expenditure in coldacclimated mice [Internet]. AJP: Endocrinology and Metabolism. 2021 ; 321 E592–E605.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1152/ajpendo.00587.2020
Vancouver
Castro É de, Vieira T dos S, Oliveira TE, Silva MO, Andrade ML, Tomazelli CA, Peixoto AS, Sobrinho CR, Moreno MF, Gilio GR, Moreira RJ, Guimarães RC, Perandini LAB, Chimin P, Reckziegel P, Moretti EH, Steiner AA, Laplante M, Festuccia WTL. Adipocyte-specific mTORC2 deficiency impairs BAT and iWAT thermogenic capacity without affecting glucose uptake and energy expenditure in coldacclimated mice [Internet]. AJP: Endocrinology and Metabolism. 2021 ; 321 E592–E605.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1152/ajpendo.00587.2020
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PIRES, Julien Rodrigues et al. Deposition of immune complexes in gingival tissues in the presence of periodontitis and systemic lupus erythematosus. Frontiers in Immunology, v. 12, 2021Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2021.591236. Acesso em: 27 nov. 2025.
APA
Pires, J. R., Nogueira, M. R. S., Nunes, A. J. F., Degand, D. R. F., Pessoa, L. C., Damante, C. A., et al. (2021). Deposition of immune complexes in gingival tissues in the presence of periodontitis and systemic lupus erythematosus. Frontiers in Immunology, 12. doi:10.3389/fimmu.2021.591236
NLM
Pires JR, Nogueira MRS, Nunes AJF, Degand DRF, Pessoa LC, Damante CA, Zangrando MSR, Greghi SLA, Rezende MLR de, Sant'Ana ACP. Deposition of immune complexes in gingival tissues in the presence of periodontitis and systemic lupus erythematosus [Internet]. Frontiers in Immunology. 2021 ; 12[citado 2025 nov. 27 ] Available from: https://doi.org/10.3389/fimmu.2021.591236
Vancouver
Pires JR, Nogueira MRS, Nunes AJF, Degand DRF, Pessoa LC, Damante CA, Zangrando MSR, Greghi SLA, Rezende MLR de, Sant'Ana ACP. Deposition of immune complexes in gingival tissues in the presence of periodontitis and systemic lupus erythematosus [Internet]. Frontiers in Immunology. 2021 ; 12[citado 2025 nov. 27 ] Available from: https://doi.org/10.3389/fimmu.2021.591236
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIEGAS, Juliana Santos Rosa et al. Nanostructured lipid carrier co-delivering tacrolimus and TNF-α siRNA as an innovate approach to psoriasis. Drug Delivery and Translational Research, v. 10, n. 3, p. 646-660, 2020Tradução . . Disponível em: https://doi.org/10.1007/s13346-020-00723-6. Acesso em: 27 nov. 2025.
APA
Viegas, J. S. R., Praça, F. S. G., Caron, A. L., Suzuki, I. L., Silvestrini, A. V. P., Medina, W. S. G., et al. (2020). Nanostructured lipid carrier co-delivering tacrolimus and TNF-α siRNA as an innovate approach to psoriasis. Drug Delivery and Translational Research, 10( 3), 646-660. doi:10.1007/s13346-020-00723-6
NLM
Viegas JSR, Praça FSG, Caron AL, Suzuki IL, Silvestrini AVP, Medina WSG, Del Ciampo LA, Kravicz MH, Bentley MVLB. Nanostructured lipid carrier co-delivering tacrolimus and TNF-α siRNA as an innovate approach to psoriasis [Internet]. Drug Delivery and Translational Research. 2020 ; 10( 3): 646-660.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1007/s13346-020-00723-6
Vancouver
Viegas JSR, Praça FSG, Caron AL, Suzuki IL, Silvestrini AVP, Medina WSG, Del Ciampo LA, Kravicz MH, Bentley MVLB. Nanostructured lipid carrier co-delivering tacrolimus and TNF-α siRNA as an innovate approach to psoriasis [Internet]. Drug Delivery and Translational Research. 2020 ; 10( 3): 646-660.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1007/s13346-020-00723-6